In addition, in comparison to HR+/HER2− disease, the HR+/HER2+ subtype was associated more with advanced stage at diagnosis (OR, 1.46; 95% CI, 1.14–1.88; p < 0.002), as was the HR−/HER2+ subtype (OR, 1.54; 95% CI, 1.18–2.00; p = 0.001), whereas the triple-negative subtype did not reach statistical significance (p = 0.09).
← all excerpts
Association Between Obesity and Clinicopathological Profile of Patients with Newly Diagnosed Non-Metastatic Breast Cancer in Saudi Arabia.
1
0.0900
0.0900